2013European Heart JournalRequires access

Prevalence of patent foramen ovale and stroke in pulmonary embolism patients

Olivier Chiche, Mathieu Castellani, Denis Doyen, P. Moceri, D. Baudouy, R. Saady, Pierre Cerboni, E. Ferrari

Open publisher page 4 citations

Abstract

Purpose: Patent foramen ovale (PFO) is associated with paradoxical embolism and mortality in pulmonary embolism (PE). The aim of this study was to assess the prevalence of PFO comparing trans-thoracic echocardiography (TTE) and trans-oesophageal echocardiography (TOE) and its association with ischaemic stroke (as assessed by magnetic resonance imaging (MRI)) in patients hospitalized for PE. Methods and results: We prospectively enrolled 40 consecutive patients hospitalized in the cardiology department for intermediate early-mortality risk PE. Patients with recent history of stroke or contra-indication to TOE were excluded from this study. Local ethics approval was obtained for the study. Contrast TTE and TOE were performed within 5 days after admission. Mean time from admission to TOE was 3.4±1.2 days, whereas mean time to MRI was 14±5.8 days. On admission, mean systolic arterial pressure was 132±40 mmHg, mean troponine Ic was 0.4±1.7 ng/ml (normal reference value < 0.06 ng/ml) and mean BNP was 585±2200 pg/ml. PFO was found in 22.5% (n=9) and 52.5% (n=21) of our patients, respectively with TTE and TOE. Compared with TTE, TOE significantly improved the sensitivity of echocardiography in detecting PFO (p = 0.002). No significant difference on admission's characteristics was found between patients without PFO (PFO-; n=19) and patients with PFO (PFO+; n=21). On MRI evidence of recent ischaemic stroke was found in 7 PFO+ patients (33.3%), versus none in PFO- patients (p=0.004). In the sub-group of stroke patients (n=7), TOE was positive for PFO in all, whereas TTE failed to identify PFO in 3 of them (recognition of PFO, TOE vs TTE: 100 vs 57%, p=0.02). No complication of TOE occurred in our cohort (including GI-bleeding). Conclusion: PFO is frequent in patients hospitalized for intermediate risk-PE, and occurred in 52.5% of our patients. In our study, PFO is strongly associated with ischaemic stroke on MRI and recognition of PFO in patients with PE could help identifying patients with high-risk of stroke and potential bleeding complications.

About this research paper

What this paper is about

Purpose: Patent foramen ovale (PFO) is associated with paradoxical embolism and mortality in pulmonary embolism (PE). The aim of this study was to assess the prevalence of PFO comparing trans-thoracic echocardiography (TTE) and trans-oesophageal echocardiography (TOE) and its association with ischaemic stroke (as assessed by magnetic resonance imaging (MRI)) in patients hospitalized for PE. Methods and results: We prospectively enrolled 40 consecutive patients hospitalized in the cardiology department for intermediate early-mortality risk PE. Patients with recent history of stroke or contra-indication to TOE were excluded from this study. Local ethics approval was obtained for the study. Contrast TTE and TOE were performed within 5 days after admission. Mean time from admission to TOE was 3.4±1.2 days, whereas mean time to MRI was 14±5.8 days. On admission, mean systolic arterial pressure was 132±40 mmHg, mean troponine Ic was 0.4±1.7 ng/ml (normal reference value < 0.06 ng/ml) and mean BNP was 585±2200 pg/ml. PFO was found in 22.5% (n=9) and 52.5% (n=21) of our patients, respectively with TTE and TOE. Compared with TTE, TOE significantly improved the sensitivity of echocardiography in detecting PFO (p = 0.002). No significant difference on admission's characteristics was found between patients without PFO (PFO-; n=19) and patients with PFO (PFO+; n=21). On MRI evidence of recent ischaemic stroke was found in 7 PFO+ patients (33.3%), versus none in PFO- patients (p=0.004). In the sub-group of stroke patients (n=7), TOE was positive for PFO in all, whereas TTE failed to identify PFO in 3 of them (recognition of PFO, TOE vs TTE: 100 vs 57%, p=0.02). No complication of TOE occurred in our cohort (including GI-bleeding). Conclusion: PFO is frequent in patients hospitalized for intermediate risk-PE, and occurred in 52.5% of our patients. In our study, PFO is strongly associated with ischaemic stroke on MRI and recognition of PFO in patients with PE could help identifying patients with high-risk of stroke and potential bleeding complications.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Purpose: Patent foramen ovale (PFO) is associated with paradoxical embolism and mortality in pulmonary embolism (PE). The aim of this study was to assess the prevalence of PFO comparing trans-thoracic echocardiography (TTE) and trans-oesophageal echocardiography (TOE) and its association with ischaemic stroke (as assessed by magnetic resonance imaging (MRI)) in patients hospitalized for PE. Methods and results: We prospectively enrolled 40 consecutive patients hospitalized in the cardiology department for intermediate early-mortality risk PE. Patients with recent history of stroke or contra-indication to TOE were excluded from this study. Local ethics approval was obtained for the study. Contrast TTE and TOE were performed within 5 days after admission. Mean time from admission to TOE was 3.4±1.2 days, whereas mean time to MRI was 14±5.8 days. On admission, mean systolic arterial pressure was 132±40 mmHg, mean troponine Ic was 0.4±1.7 ng/ml (normal reference value < 0.06 ng/ml) and mean BNP was 585±2200 pg/ml. PFO was found in 22.5% (n=9) and 52.5% (n=21) of our patients, respectively with TTE and TOE. Compared with TTE, TOE significantly improved the sensitivity of echocardiography in detecting PFO (p = 0.002). No significant difference on admission's characteristics was found between patients without PFO (PFO-; n=19) and patients with PFO (PFO+; n=21). On MRI evidence of recent ischaemic stroke was found in 7 PFO+ patients (33.3%), versus none in PFO- patients (p=0.004). In the sub-group of stroke patients (n=7), TOE was positive for PFO in all, whereas TTE failed to identify PFO in 3 of them (recognition of PFO, TOE vs TTE: 100 vs 57%, p=0.02). No complication of TOE occurred in our cohort (including GI-bleeding). Conclusion: PFO is frequent in patients hospitalized for intermediate risk-PE, and occurred in 52.5% of our patients. In our study, PFO is strongly associated with ischaemic stroke on MRI and recognition of PFO in patients with PE could help identifying patients with high-risk of stroke and potential bleeding complications.

Key concepts: Medicine, Patent foramen ovale, Paradoxical embolism, Internal medicine, Stroke (engine), Cardiology, Pulmonary embolism, Magnetic resonance imaging

Related papers

Back to paper searchBrowse research topicsOriginal source
Prevalence of patent foramen ovale and stroke in pulmonary embolism patients — Research Paper | ScholarLens